US OptionsDetailed Quotes
AMED241220C105000
- 0.10
- 0.000.00%
15min DelayClose Nov 22 15:59 ET
0.00High0.00Low
0.10Open0.10Pre Close0 Volume2.07K Open Interest105.00Strike Price0.00Turnover29.51%IV15.95%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier26DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0363Delta0.0112Gamma906.40Leverage Ratio-0.0111Theta0.0023Rho32.92Eff Leverage0.0192Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?